Fingerprint
Dive into the research topics of 'Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US
Ralph P. Insinga, David J. Vanness, Josephine L. Feliciano, Kristel Vandormael, Sory Traore, Thomas Burke
Research output: Contribution to journal › Article › peer-review
79
Scopus
citations